Caricamento...
Sorafenib- Taurine Combination Model for Hepatocellular Carcinoma Cells: Immunological Aspects
Sorafenib (Sor) is a multi-kinase inhibitor. It is recommended for the treatment of advanced hepatocellular carcinoma (HCC). However, Sor has severe and marked side effects. On the other hand, taurine (Tau) has been shown to enhance the therapeutic effects of cancer chemotherapy and also to enhance...
Salvato in:
| Pubblicato in: | Asian Pac J Cancer Prev |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
West Asia Organization for Cancer Prevention
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6982677/ https://ncbi.nlm.nih.gov/pubmed/31653148 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.31557/APJCP.2019.20.10.3007 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|